Bernard S. Goffe

4.3k total citations · 2 hit papers
23 papers, 3.3k citations indexed

About

Bernard S. Goffe is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Bernard S. Goffe has authored 23 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 7 papers in Dermatology and 7 papers in Rheumatology. Recurrent topics in Bernard S. Goffe's work include Psoriasis: Treatment and Pathogenesis (13 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and Dermatology and Skin Diseases (5 papers). Bernard S. Goffe is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (13 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and Dermatology and Skin Diseases (5 papers). Bernard S. Goffe collaborates with scholars based in United States, Canada and France. Bernard S. Goffe's co-authors include Philip J. Mease, James M. Metz, Daniel Burge, Barbara Finck, Ann VanderStoep, Alice B. Gottlieb, Craig L. Leonardi, Ralph Zitnik, Robert Matheson and Andrea Wang and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Bernard S. Goffe

23 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

2000 1.1k citations Philip J. Mease, Bernard S. Goffe et al. The Lancet profile →
Etanercept as Monotherapy in Patients with Psoriasis

2003 935 citations Craig L. Leonardi, Robert Matheson et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernard S. Goffe United States	16	2.4k	1.4k	940	764	314	23	3.3k
Robert Matheson United States	13	2.0k 0.8×	499 0.4×	1.2k 1.3×	331 0.4×	299 1.0×	20	2.7k
B. Randazzo United States	29	2.7k 1.2×	565 0.4×	1.7k 1.8×	547 0.7×	384 1.2×	71	3.9k
Jeffrey Crowley United States	24	1.5k 0.6×	407 0.3×	866 0.9×	250 0.3×	312 1.0×	64	1.9k
Lisa T. Dooley United States	14	5.4k 2.3×	1.3k 0.9×	2.9k 3.1×	873 1.1×	969 3.1×	15	6.1k
Philippe Musette France	29	1.5k 0.7×	1.4k 1.0×	514 0.5×	178 0.2×	832 2.6×	77	3.6k
Sylvia Hsu United States	23	1.1k 0.5×	460 0.3×	1.0k 1.1×	202 0.3×	613 2.0×	142	2.2k
Mark Goodfield United Kingdom	27	768 0.3×	725 0.5×	863 0.9×	209 0.3×	363 1.2×	81	2.1k
Joung-Liang Lan Taiwan	17	1.3k 0.5×	1.9k 1.4×	193 0.2×	196 0.3×	487 1.6×	24	3.2k
Francesco Caso Italy	35	1.9k 0.8×	2.0k 1.5×	297 0.3×	1.0k 1.3×	188 0.6×	137	3.9k
Andrea Matucci Italy	32	1.3k 0.5×	675 0.5×	309 0.3×	215 0.3×	197 0.6×	114	3.2k

Countries citing papers authored by Bernard S. Goffe

Since Specialization

Citations

This map shows the geographic impact of Bernard S. Goffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard S. Goffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard S. Goffe more than expected).

Fields of papers citing papers by Bernard S. Goffe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard S. Goffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard S. Goffe. The network helps show where Bernard S. Goffe may publish in the future.

Co-authorship network of co-authors of Bernard S. Goffe

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard S. Goffe. A scholar is included among the top collaborators of Bernard S. Goffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard S. Goffe. Bernard S. Goffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lowe, Nicholas J., et al.. (2021). Assessment of Natural Sunlight Protection Provided by 10 High-SPF Broad-Spectrum Sunscreens and Sun-Protective Fabrics. Current problems in dermatology. 55. 157–169. 9 indexed citations

Carr, David, Mark G. Tusa, Christie L. Carroll, et al.. (2008). Open label trial of alefacept in palmoplantar pustular psoriasis. Journal of Dermatological Treatment. 19(2). 97–100. 17 indexed citations

Gottlieb, Alice B., Craig L. Leonardi, Bernard S. Goffe, et al.. (2006). Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database. Journal of the American Academy of Dermatology. 54(3). S92–S100. 57 indexed citations

Papp, Kim, Scott Fretzin, Bernard S. Goffe, et al.. (2006). Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial. International Journal of Dermatology. 45(5). 605–614. 55 indexed citations

Goffe, Bernard S., Kim Papp, David Gratton, et al.. (2005). An integrated analysis of thirteen trials summarizing thelong-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy. Clinical Therapeutics. 27(12). 1912–1921. 44 indexed citations

Goffe, Bernard S.. (2005). Etanercept (Enbrel) -- an update.. PubMed. 9(10). 1–4, 9. 15 indexed citations

Mease, Philip J. & Bernard S. Goffe. (2004). Diagnosis and treatment of psoriatic arthritis. Journal of the American Academy of Dermatology. 52(1). 1–19. 94 indexed citations

Gottlieb, Alice B., Bernard S. Goffe, Joachim Veith, & Seth R. Stevens. (2004). Safety of etanercept in an integrated multi-study database of patients with psoriasis. Journal of the American Academy of Dermatology. 50(3). P158–P158. 8 indexed citations

Leonardi, Craig L., et al.. (2004). The safety of efalizumab in patients with moderate to severe plaque psoriasis: summary of clinical trial experience. Journal of the American Academy of Dermatology. 50(3). P157–P157. 4 indexed citations

10.

Goffe, Bernard S., Alice B. Gottlieb, Mark Lebwohl, & Ralph Zitnik. (2004). Etanercept in patients with psoriatic arthritis: sustained improvement in skin and joint disease. Journal of the American Academy of Dermatology. 50(3). P55–P55. 5 indexed citations

11.

Gottlieb, Alice B., Thomas B. Casale, Ellen Frankel, et al.. (2003). CD4+ T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study. Journal of the American Academy of Dermatology. 49(5). 816–825. 66 indexed citations

12.

Leonardi, Craig L., Robert Matheson, Bernard S. Goffe, et al.. (2003). Etanercept as Monotherapy in Patients with Psoriasis. New England Journal of Medicine. 349(21). 2014–2022. 935 indexed citations breakdown →

13.

Mease, Philip J., Bernard S. Goffe, James M. Metz, et al.. (2000). Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. The Lancet. 356(9227). 385–390. 1111 indexed citations breakdown →

14.

Lebwohl, Mark, Cynthia Guzzo, Brian V. Jegasothy, et al.. (1999). CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. Journal of Clinical Investigation. 103(9). 1243–1252. 473 indexed citations

15.

Lebwohl, Mark, Debra Breneman, Bernard S. Goffe, et al.. (1998). Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. Journal of the American Academy of Dermatology. 39(4). 590–596. 106 indexed citations

16.

Guzzo, Cynthia, Gerald S. Lazarus, Bernard S. Goffe, et al.. (1996). Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis. Journal of the American Academy of Dermatology. 34(3). 429–433. 18 indexed citations

17.

Tack, Kenneth J., et al.. (1991). Cefpodoxime Proxetil in the Treatment of Skin and Soft Tissue Infections. Drugs. 42(Supplement 3). 51–56. 21 indexed citations

18.

DODD, W. ALAN, Bernard S. Goffe, R. W. Goltz, et al.. (1990). A trial of the Actiderm dermatological patch and topical corticosteroids in the treatment of psoriasis vulgaris. Cutis. 46(1). 84–88. 6 indexed citations

19.

Turck, Marvin, Bernard S. Goffe, & Robert G. Petersdorf. (1963). The urethral catheter and urinary tract infection. Plastic & Reconstructive Surgery. 31(4). 396–396. 1 indexed citations

20.

Turck, Marvin, Bernard S. Goffe, & Robert G. Petersdorf. (1962). The Urethral Catheter and Urinary Tract Infection. The Journal of Urology. 88(6). 834–837. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact